Fred Alger Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Sell |
|
|||||
|
2025
Q1 | $6.46M | Buy |
|
|||||
|
2024
Q4 | $2.12M | Sell |
|
|||||
|
2024
Q3 | $8.39M | Sell |
|
|||||
|
2024
Q2 | $28.2M | Buy |
|
|||||
|
2024
Q1 | $24.8M | Sell |
|
|||||
|
2023
Q4 | $86.9M | Sell |
|
|||||
|
2023
Q3 | $75.5M | Buy |
|
|||||
|
2023
Q2 | $71.3M | Buy |
|
|||||
|
2023
Q1 | $53.6M | Sell |
|
|||||
|
2022
Q4 | $117M | Sell |
|
|||||
|
2022
Q3 | $153M | Buy |
|
|||||
|
2022
Q2 | $140M | Buy |
|
|||||
|
2022
Q1 | $113M | Buy |
|
|||||
|
2021
Q4 | $85.5M | Buy |
|
|||||
|
2021
Q3 | $487K | Sell |
|
|||||
|
2021
Q2 | $566K | Sell |
|
|||||
|
2021
Q1 | $40.7M | Sell |
|
|||||
|
2020
Q4 | $133M | Sell |
|
|||||
|
2020
Q3 | $288M | Sell |
|
|||||
|
2020
Q2 | $324M | Sell |
|
|||||
|
2020
Q1 | $390M | Buy |
|
|||||
|
2019
Q4 | $354M | Buy |
|
|||||
|
2019
Q3 | $243M | Buy |
|
|||||
|
2019
Q2 | $245M | Sell |
|
|||||
|
2019
Q1 | $252M | Sell |
|
|||||
|
2018
Q4 | $330M | Buy |
|
|||||
|
2018
Q3 | $383M | Buy |
|
|||||
|
2018
Q2 | $333M | Buy |
|
|||||
|
2018
Q1 | $288M | Sell |
|
|||||
|
2017
Q4 | $303M | Buy |
|
|||||
|
2017
Q3 | $262M | Buy |
|
|||||
|
2017
Q2 | $209M | Buy |
|
|||||
|
2017
Q1 | $132M | Sell |
|
|||||
|
2016
Q4 | $100M | Sell |
|
|||||
|
2016
Q3 | $140M | Buy |
|
|||||
|
2016
Q2 | $138M | Sell |
|
|||||
|
2016
Q1 | $156M | Sell |
|
|||||
|
2015
Q4 | $287M | Sell |
|
|||||
|
2015
Q3 | $254M | Buy |
|
|||||
|
2015
Q2 | $98.7M | Buy |
|
|||||
|
2015
Q1 | $36.4M | Buy |
|
|||||
|
2014
Q4 | $26.9M | Sell |
|
|||||
|
2014
Q3 | $41M | Sell |
|
|||||
|
2014
Q2 | $35.4M | Sell |
|
|||||
|
2014
Q1 | $52.5M | Buy |
|
|||||
|
2013
Q4 | $44.8M | Sell |
|
|||||
|
2013
Q3 | $54.3M | Sell |
|
|||||
|
2013
Q2 | $91.6M | Buy |
|